Omega-3 fatty acids and cardiovascular disease risk: Do we understand the relationship?

Physiological Research

Volumn 58, Issue SUPPL.1, 2009, Pages

  Vrablik M ^a   Prusikova M ^a   Snejdrlova M ^a   Zlatohlavek L ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cardiovascular event; Cardiovascular risk; DHA; EPA; Omega 3 fatty acids; Omega 3 index

Indexed keywords

OMEGA 3 FATTY ACID;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIET SUPPLEMENTATION; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; METABOLISM; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FATTY ACIDS, OMEGA-3; HUMANS; NUTRITION POLICY; RISK ASSESSMENT; RISK FACTORS;

EID: 72649102972     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (37)

1. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J: Blood levels of longchain n-3 fatty acids and the risk of sudden death. N Engl J Med 346: 1113-1118, 2002.
2. Bhatnagar D, Durrington PN : Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications. Int J Clin Pract 57: 305-314, 2003.
3. Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA : EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 197: 821-828, 2008.
4. Brenna JT: Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 5: 127-132, 2002.
5. Brunton S, Collins N: Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids. Curr Med Res Opin 23: 1139-1145, 2007.
6. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2: 757-761, 1989.
7. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, redberg R, Stitzel KF, Stone NJ: Primary prevention of cardiovascular diseases in people with diabetes mellitus. Circulation 115: 114-126, 2007.
8. Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN: COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo controlled study. Clin Ther 29: 1354-1367, 2007.
9. Din JN, Harding SA, Valerio CJ, Sarma J, Lyall K, Riemersma RA, Newby DE, Flapan AD: Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis 197: 290-296, 2008.
10. Din JN, Newby DE, Flapan AD: Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment. BMJ 328: 30-35, 2004.
11. Gissi-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455, 1999.
12. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Opreimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL: European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis 194: 1-45, 2007.
13. Grimsgaard S, Bønaa KH, Hansen JB, Myhre ES: Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 68: 52-59, 1998.
14. Harris WS: n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65 (Suppl): 1645s-1654s, 1997.
15. Harris WS, Ginsberg HN, Arunakul N, Shachter NS, Windsor SL, Adams M, Berglund L, Osmundsen K: Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovas Risk 4: 385-391, 1997.
16. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JP, Capps NE, Riemersma RA, Ebrahim SB, Davey Smith G: Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 332: 752-760, 2006.
17. Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M, Kawano H, Yano T, Aoe S, Takeya M, Shimatsu A, Kuzuya H, Kamei Y, Ogawa Y: Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27: 1918-1925, 2007.
18. Kris-Etherton PM, Harris WS, Appel LJ: American Heart Association Nutrition Committee: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 107: 2747-2757, 2003.
19. Larson MK, Ashmore JH, Harris KA, Vogelaar JL, Pottala JV, Sprehe M, Harris WS: Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. Thromb Haemost 100: 634-641, 2008.
20. Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS: Omega-3 fatty acids for cardioprotection. Mayo Clin Proc 83: 324-332, 2008.
21. Lee KW, Blann AD, Lip GY: Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction. Thromb Res 118: 305-312, 2006.
22. León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT: Effect of fish oil on arrythmias and mortality: systematic review. BMJ 337: 2931-2938, 2008.
23. Matsuzaki M, Yokoyama M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Matsuzawa Y: The JELIS Investigators: Incremental Effects of Eicosapentaenoic Acid on Cardiovascular Events in Statin-Treated Patients With Coronary Artery Disease. Circ J 2009 (in press).
24. Mehra MR, Lavie CJ, Ventura HO, Milani RV: Fish oils produce antiinflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant 25: 834-838, 2006.
25. Mori TA, Bao DQ, Burke V, Puddey IB, Beilin LJ: Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34: 253-260, 1999.
26. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ: Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71: 1085-1094, 2000.
27. Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ: Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers, in treated-hypertensive Type 2 diabetic subjects. Free Rad Biol Med 35: 772-781, 2003.
28. Morris MC, Sacks F, Rosner B: Does fish oil lower blood pressure: a meta-analysis of controlled trials. Circulation 88: 523-533, 1993.
29. Ness AR, Hughes J, Elwood PC, Whitley E, Smith GD, Burr ML: The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial (DART). Eur J Clin Nutr 56: 512-518, 2002.
30. Nettleton JA: Omega-3 fatty acids: comparison of plant and seafood sources in human nutrition. J Am Diet Assoc 91: 331-337, 1991.
31. Plourde M, Cunnane SC: Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32: 619-634, 2007.
32. Saito Y, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K: Jelis Investigators, Japan: Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 200: 135-140, 2008.
33. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC, Grimble RF: Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361: 477-485, 2003.
34. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J: N-3 fatty acids from fish or fish oil supplements, but not alpha-linolenic acid, bendit cardiovascular disease outcomes in primary-and secondary- prevention studies: a systematic review. Am J Clin Nutr 84: 5-17, 2006.
35. Woodman RJ, Mori TA, Burke V, Puddey IB, Barden A, Watts GF, Beilin LJ: Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrilolytic and vascular function in Type 2 diabetic patients. Atherosclerosis 166: 85-93, 2003.
36. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K: Japan EPA lipid intervention study (JELIS) Investigators: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis Lancet 369: 1090-1098, 2007
37. Zhang J, Sasaki S, Amano K, Kesteloot H: Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study. Prev Med 28: 520-529, 1999.